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Saccharomyces cerevisiae Rio2p (encoded by open
reading frame Ynl207w) is an essential protein of un-
known function that displays significant sequence sim-
ilarity to Rio1p/Rrp10p. The latter was recently shown
to be an evolutionarily conserved, predominantly cyto-
plasmic serine/threonine kinase whose presence is re-
quired for the final cleavage at site D that converts 20 S
pre-rRNA into mature 18 S rRNA. A data base search
identified homologs of Rio2p in a wide variety of eu-
karyotes and Archaea. Detailed sequence comparison
and in vitro kinase assays using recombinant protein
demonstrated that Rio2p defines a subfamily of protein
kinases related to, but both structurally and function-
ally distinct from, the one defined by Rio1p. Failure to
deplete Rio2p in cells containing a GAL-rio2 gene and
direct analysis of Rio2p levels by Western blotting indi-
cated the protein to be low abundant. Using a GAL-rio2
gene carrying a point mutation that reduces the kinase
activity, we found that depletion of this mutant protein
blocked production of 18 S rRNA due to inhibition of the
cleavage of cytoplasmic 20 S pre-rRNA at site D. Produc-
tion of the large subunit rRNAs was not affected. Thus,
Rio2p is the second protein kinase that is essential for
cleavage at site D and the first in which the processing
defect can be linked to its enzymatic activity. Contrary
to Rio1p/Rrp10p, however, Rio2p appears to be localized
predominantly in the nucleus.
Like their counterparts in other eukaryotes, Saccharomyces
cerevisiae ribosomes contain four species of rRNA: 5 S, 5.8 S, 18
S, and 25 S rRNAs. The genes encoding these rRNAs are
organized on the yeast genome in 150–200 tandem repeats,
each of which comprises two transcriptional units separated by
non-transcribed spacers. One of these units consists of a 5 S
rRNA gene, transcribed by RNA polymerase III. The other unit
contains single genes for each of the mature 18 S, 5.8 S, and 25
S rRNAs that are separated by internal transcribed spacers 1
and 2, whereas external transcribed spacer regions are present
at either end of the unit (see Fig. 1A). After transcription of this
polycistronic unit by RNA polymerase I, the spacers are re-
moved from the primary transcript via an ordered series of
endo- and exonucleolytic cleavages (see Fig. 1B) (reviewed in
Refs. 1 and 2). The first detectable precursor species is 35 S
pre-rRNA, which results from a cleavage at site B0 in the
3-external transcribed spacer by the yeast RNase III homolog
Rnt1p (3, 4). Subsequent cleavage at sites A0 and A1 in the
5-external transcribed spacer first gives rise to 33 S and then
32 S pre-rRNA. The latter is cleaved at site A2 to produce
separate 20 S and 27 S A2 precursors for the small and large
ribosomal subunit, respectively.
The majority (90%) of the 27 S A2 precursor molecules are
cleaved endonucleolytically at site A3, followed by exonucleo-
lytic trimming to B1S. The remainder are processed endonu-
cleolytically1 at site B1L. The resulting 27 S BS and 27 S BL
precursors, whose 5-ends are located 6 nucleotides apart, are
then converted into 25 S rRNA and the “short” and “long” forms
of 5.8 S rRNA, respectively, in the same manner (5–9). All of
the above processing steps, as well as the concomitant assem-
bly of most of the ribosomal proteins, take place in the nucle-
olus/nucleoplasm. However, the final step in 40 S subunit bio-
genesis in yeast occurs after export of the pre-40 S ribosomal
subunit to the cytoplasm, where its 20 S pre-rRNA is processed
at site D to produce the mature 18 S rRNA (10, 11). Pre-rRNA
processing in other eukaryotic cells follows a similar pathway,
except that maturation of 18 S rRNA is completed in the
nucleus rather than the cytoplasm.
Although the pre-rRNA processing pathway itself is now well
understood, many questions pertaining to its control and its
integration with the assembly of the ribosomal proteins remain
to be answered. Presently, 100 non-ribosomal proteins or
trans-acting factors have been identified that are essential for
ribosome biogenesis in S. cerevisiae (1, 12, 13). Recent advances
in the purification and characterization of large (ribonucleo)-
protein complexes have pushed the number of potential trans-
acting factors even higher. Moreover, it has become clear that
these factors form two largely independent, dynamic process-
ing/assembly machineries for the small and large subunits,
respectively (12, 14–17). Very little is known as yet about the
exact function of any of the parts of these machineries or the
manner in which they cooperate.
Virtually all of the trans-acting factors presently known to be
involved in biogenesis of the yeast 40 S subunit are required for
the formation of 20 S pre-rRNA by the early processing cleav-
ages at sites A0, A1, and A2. These factors assemble cotrans-
criptionally on the pre-rRNA in the nucleolus, together with
some of the ribosomal proteins, to form the 80–90 S small
subunit pre-ribosome and, at least for the most part, appear to
dissociate prior to export of the pre-40 S particle to the cyto-
plasm (1, 12, 14, 15). However, a number of trans-acting factors
remain associated or join the pre-40 S particle in the nucleo-
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plasm and accompany it upon export to the cytoplasm (18). One
of these factors is Rrp10p, which is essential for the conversion
of 20 S pre-rRNA into mature 18 S rRNA and was identified in
a synthetic lethality screen with a mutant of Gar1p (11), one of
the core proteins of box H/ACA small nucleolar ribonucleopro-
teins. Interestingly, Rrp10p, also known as Rio1p (19), was
subsequently shown to be a member of a novel subfamily of
serine/threonine protein kinases with family members in eu-
karyotes, Archaea, and prokaryotes (20–22). Homologs of
Rio1p in other organisms have been implicated in cell cycle
progression, and it has been reported that depletion of Rio1p in
yeast causes arrest in the G1 phase of the cell cycle (21, 22). The
connection between these two functions of Rio1p/Rrp10p and
its enzymatic activity remains unclear.
In yeast, the open reading frame Ynl207w encodes a protein
called Rio2p that has 19% identity and 49% similarity to Rio1p/
Rrp10p. The function of Rio2p in yeast cells is unknown, but
obviously differs from that of Rio1p/Rrp10p as both proteins
are essential. A systematic analysis of several hundreds of
yeast protein complexes isolated by tandem-affinity purifica-
tion (23) demonstrated the association of Rio2p on the one hand
with a number of proteins required late in 40 S subunits bio-
genesis such as Trs1p, Rrp12p, and Dim1p and on the other
hand with several proteins implicated in cell growth and main-
tenance (24, 25). In this study, we present evidence that Rio2p
is a member of a second subfamily of protein kinases and, like
Rio1p, is essential for cleavage at site D, the final processing
step in the formation of mature 18 S rRNA.
EXPERIMENTAL PROCEDURES
Strains and Plasmids—The yeast strains and plasmids used in this
study are listed in Tables I and II. All strains were grown on yeast
nitrogen base medium (Difco) containing the relevant amino acids and
either 2% (w/v) glucose or galactose. Plates also contained 2% agar
(Bacto-agar, Difco). During determination of growth rates, cells were
kept in logarithmic growth by regular dilution with prewarmed me-
dium. All optical density measurements were performed at 660 nm on
a Novaspec 550 spectrophotometer (Amersham Biosciences).
The basal strain for our analysis was constructed by first transform-
ing the diploid Y22005 strain carrying a rio2 gene inactivated by inser-
tion of the kanamycin marker on one of its chromosomes (obtained from
EUROSCARF) with the centromeric pWTR2(URA3) plasmid carrying a
wild-type copy of the RIO2 gene. The resulting transformants were
sporulated using the method described on the EUROSCARF site,2
except that our pre-sporulation plates contained 2 yeast nitrogen
base medium and 5% (w/v) glucose and lacked uracil to select for the
presence of the plasmid. After growing the dissected spores on YPD
(1% yeast extract, 2% peptone, and 2% dextrose) plates, haploid
transformants containing the inactivated rio2 gene were identified by
PCR. The selected haploid strain containing the rio2::kan gene was
called YTV101. The pWTR2 plasmid present in the cells was replaced
by the pGalR2(HIS3) plasmid or its mutant counterparts by plasmid
shuffling.
Construction of Plasmid-encoded Wild-type and Mutant RIO2 Genes
and RIO2 Fusion Genes—A plasmid-encoded copy of the RIO2 gene
under the control of its own promoter was constructed by amplifying the
gene including 300 bp of its upstream sequence with the R2B1fw and
R2E1rv primers (Table III). The resulting product was inserted be-
tween the BamHI and EcoRI sites of pRS316(URA3) (26), resulting in
plasmid pWTR2. The RIO2 gene was fused to the GAL1-10 promoter by
first amplifying it using the R2E1fw and R2S1rv primers (Table III).
The resulting product was inserted into pTL26(HIS3) (27) between the
EcoRI and XhoI sites to give the pGalR2 plasmid.
Point mutations (see Fig. 2) were introduced into the RIO2 coding
region by site-directed mutagenesis via the megabase primer method
(28) using the unique AvaI, BstEII, and HincII sites in the RIO2 gene
carried on the pGalR2 plasmid. The oligonucleotides used for mutagen-
esis are listed in Table III.
A GST3-RIO2 fusion was constructed by amplification of the RIO2
gene using the R2N1fw and R2E1rv primers (Table III). The former
primer introduces an NcoI site at the ATG start codon of the RIO2
coding region. The PCR product was inserted between the NcoI and
EcoRI sites of plasmid pRP261, a derivative of pGEX1 (29) that fuses
the RIO2 and GST coding regions in-frame. This plasmid was trans-
formed into the Escherichia coli Sure strain (Stratagene), and expres-
sion of the fusion protein was induced by the addition of 1 mM isopropyl-
-D-thiogalactopyranoside to an exponentially growing culture. After an
additional 2 h at 30 °C, cells were collected and broken by sonication in
lysis buffer containing 20% (v/v) glycerol, 50 mM Tris-HCl (pH 8.0), 125
mM NaCl, 2.5 mM MgCl2, 1 mM DTT, 0.1 mM EDTA, and 0.1% Nonidet
P-40. The extract was centrifuged for 15 min at 14,000 rpm in an
Eppendorf centrifuge to remove the cell debris. Glutathione-Sepharose
beads (400 l; Amersham Biosciences) were added to the resulting
supernatant. After incubation for 30 min at 4 °C, the beads were
washed three times with lysis buffer. GST-Rio2p(D229A) was purified
in the same manner from cells expressing a derivative plasmid in which
the wild-type RIO2 coding region had been replaced by the mutant
version.
Biochemical Fractionation—20 OD660 units of yeast cells harvested
during mid-logarithmic growth were resuspended in buffer A (1 M
sorbitol, 50 mM Tris-HCl (pH 8.0), and 10 mM MgCl2) containing 30 mM
DTT and incubated at room temperature for 15 min. The cells where
then pelleted by centrifugation in an Eppendorf centrifuge for 1 min at
3000 rpm, resuspended in buffer A containing 3 mM DTT and 0.45
mg/ml zymolyase (Seikagaku), and incubated at 30 °C for 60 min. The
cells were pelleted, washed with ice-cold buffer A, and resuspended in
buffer B (15 mM KCl, 10 mM Tris-HCl (pH 8.0), 5 mM MgCl2, 0.1 mM
EDTA, and 3 mM DTT) using a homogenizer with a loose-fitting pestle.
The cell suspension was incubated at 4 °C for 20 min and then broken
with five strokes of a tight-fitting pestle. The resulting homogenate was
separated into a cytoplasmic and a nuclear fraction by centrifugation
for 20 min at 13,000 rpm in an Eppendorf centrifuge at 4 °C.
RNA and Protein Analysis—Total RNA was isolated by resuspending
20 OD660 units of cells in 600 l of buffer (10 mM Tris-HCl (pH 7.5), 10
mM EDTA, and 0.5% (w/v) SDS) and 600 l of water-saturated phenol.
After adding 100 l of glass beads (diameter, 0.5–0.8 mm), the samples
were heated at 65 °C for 1 h under continuous stirring. The aqueous
phase was re-extracted with phenol and again with 600 l of chloro-
form/isoamyl alcohol (24:1, v/v). RNA was precipitated by adding 40 l
of 3 M NaAc (pH 5.2) and 800 l of EtOH and redissolved in RNase-free
distilled water to a concentration of 0.4 A260/l. Northern analysis was
performed as described previously using the various probes indicated in
Fig. 1A (30).
Protein extracts for Western blotting were prepared by lysing the
cells in 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, 0.1 M NaCl, and 1 mM
DTT with glass beads (diameter, 0.5–0.8 mm) by vortexing for 5 min.
The extracts were subjected to SDS-PAGE on 12% minigels (Bio-Rad).
After blotting onto nylon membrane (Protran, Schleicher & Schu¨ll)
and incubation with horse radish peroxidase-labeled antibodies
against the protein A epitope, bound antibody was visualized using
nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate coloring
reaction.
In Vitro Kinase Assays—The auto- and heterophosphorylating activ-
2 Available at www.uni-frankfurt.de/fb15/mikro/euroscarf/index/html.
3 The abbreviations used are: GST, glutathione S-transferase; DTT,
dithiothreitol; MBP, myelin basic protein; PAA, polyacrylamide; TAP,
tandem affinity purification.
TABLE I
S. cerevisiae strains used in this study
Strain Genotype Ref.
Y22005 Mata/, his31/his31, leu20/leu20, lys20/LYS2, MET15/met150, ura30/ura30,
ynl207w::kanMX4/YNL207w
EUROSCARF
SC1413 Mata, ade2, arg4, leu2–3,112, trp1–289, ura3–52, YNL207w::TAP-K.I.URA3 EUROSCARF
SC1110 Mata, ade2, arg4, leu2–3,112, trp1–289, ura3–52, YHR089c::TAP-K.I.URA3 EUROSCARF
YTV101 Mata, his31, leu20, ura30, yn1207w::kanMX4 (pWTR2) This work
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ities of recombinant GST-Rio2p were determined by incubating 5 l of
Sepharose-glutathione-bound GST-Rio2p beads in 20 l of buffer con-
taining 50 mM Tris-HCl (pH 7.2), 5 mM MgCl2, and 1 Ci of [-
32P]ATP
(10 mCi/ml; Amersham Biosciences) either with or without 5 mM
MnCl2. To determine the ability of Rio2p to heterophosphorylate a
substrate, 4 g of myelin basic protein (MBP; Sigma) was added to the
reaction mixture. The samples were analyzed by electrophoresis on a
12% SDS-PAA gel, followed by autoradiography. The amount of GST-
Rio2p present in the reaction mixture was assayed by staining with
Coomassie Brilliant Blue
RESULTS
Rio2p Is a Member of a Distinct Subfamily of Putative Pro-
tein Kinases—The S. cerevisiae open reading frame Ynl207w
encodes a protein, designated Rio2p (19), that shows significant
structural similarity to Rio1p/Rrp10p. The latter was found to
be essential for endonucleolytic cleavage at site D, the final
step in the formation of mature 18 S rRNA (11). Subsequently,
it was characterized as a predominantly cytoplasmic serine/
threonine protein kinase conserved from bacteria to man with
a role in cell cycle progression (20–22).
Fig. 2 shows the results of an alignment of Rio1p/Rrp10p and
Rio2p, demonstrating that the sequence similarities between
the two proteins are predominantly confined to three regions
indicated as I, II, and III.4 Regions I and III contain the puta-
tive ATP-binding and kinase domains, respectively (22). This
result suggests that Rio2p also is a protein kinase, but may
belong to a subfamily distinct from the one defined by
Rio1p/Rrp10p.
Using the Rio2p sequence as our starting point, we searched
the NCBI Protein Database for homologs of Rio2p in other
organisms and identified a number of such homologs in both
eukaryotes and Archaea. Alignment of these homologs revealed
a pattern of sequence conservation that is distinct from the one
between Rio2p and Rio1p (Fig. 2). First, the N-terminal regions
of the various Rio2 proteins show marked similarity, but differ
considerably from the corresponding region in Rio1p, which is
not significantly conserved in the latter subfamily (20, 22).
Second, within the regions that are conserved between Rio1p
and Rio2p, conservation within each of the two subfamilies is
higher than between the two subfamilies (Fig. 2). From these
data, we conclude that Rio2p defines a putative protein kinase
subfamily that is related to, but distinct from, the one founded
by Rio1p/Rrp10p. Phylogenetic analysis (Fig. 3) adds further
support to this conclusion. This analysis clearly shows an early
division between Rio1p- and Rio2p-like proteins. Furthermore,
a small number of (archae)bacterial Rio-like proteins seem to
from a third subfamily.
Interestingly, our data base search did not identify any eu-
bacterial members of the Rio2p subfamily. Thus, whereas eu-
karyotes and Archaea have at least one gene member in both
the RIO1 and RIO2 subfamily, the latter seems to be absent
from the eubacterial kingdom. This suggests that the two types
of subfamily originated from duplication of an ancestral gene
that occurred before the split between Archaea and eukaryotes.
Because Rio1p and Rio2p are both essential in yeast, the two
genes gained different functions.
Low Level Expression of Rio2p Is Sufficient to Support Nor-
mal Growth—To study the role of Rio2p in yeast in more detail,
we constructed a mutant strain that conditionally expresses
the protein. As the starting point, we used the diploid strain
Y22005 obtained from EUROSCARF. This strain contains a
rio2 gene that has been disrupted by insertion of the kana-
mycin gene on one of its chromosomes.4 A detailed alignment is available upon request.
TABLE II
Plasmids used in this study
Plasmid Ref.
pTL26 HIS3, CEN/ARS, Amp, GAlI-10 27
pRS316 URA3, CEN/ARS, Amp 26
pWTR2 Derived from pRS316 by insertion of RIO2 under its own promoter between BamHI
and EcoRI sites
This work
pGalR2 Derived from pTL26 by insertion of the GAL-rio2 gene between EcoRI and XhoI sites This work
pGalR2(D229A) Identical to pGalR2, but containing D229A mutation in RIO2 coding region This work
pGSTR2 Derivative of pGEX1 containing GST-RIO2 fusion gene This work
pGSTR2(D229A) Identical to pGSTR2, but containing D229A mutation in RIO2 coding region This work
TABLE III
Sequences of oligonucleotides used in this work either as probes in Northern hybridization or
as primers during construction of the various RIO2 genes
All sequences are shown 5 3 3. The position of the probes are indicated in Fig. 1A. Sequence alterations used in the introduction of point
mutations are in boldface, and the nature of the mutation is indicated.
Probes Sequence
1 GAAATCTCTCACCGTTTGGAATACG
2 TGTTACCTCTGGGCCC
3 GGCCAGCAATTTCAAGTTAA
Primers
R2E1fw AAAAAGAATTCTCAGACTAGAATGAAATTGGATAC
R2E1rv AAAAAGAATTCGAACAACTTGATTATTTGCGGC
R2B1fw AAAAAGGATCCGGCTCACGTTGGTGAATGGCT
R2S1rv AAAAAGTCGACAACAACTTGATTATTTGCGGC
Ava1fw CGAAGTCGTTCCAACTCCCTTG
Bstefw GGAGCTTATCGAGGGTTACCC
Bsterv CTCCTCATTGGGTAACCC
Hincrv TCAGTTTCTTTTTGAAGAAACGACG
VVI CGCGTCATATAGTCGTTAAGGAGCTTATCGAGGGTTACCC (M189K)
VVK CGCGTCATATAGTCGTTATTGAGCTTATCGAGGGTTACCC (M189I)
GRES CGGTAACACTATTGGTGTTGGTATTGAATCTGACATCTATAAAGTAAG (K105R)
GIES CGGTAACACTATTGGTGTTGGTAGGGAATCTGACATCTATAAAGTAAG (K105I)
GLIFCD GCAAATAGCGGACTTATCTTTTGTGATTTTAATGAGTTTAATATT (H227F)
GLIYCD GCAAATAGCGGACTTATCTATTGTGATTTTAATGAGTTTAATATT (H227Y)
GLIHCA GCAAATAGCGGACTTATCCATTGTGCTTTTAATGAGTTTAATATT (D229A)
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Diploid Y22005 cells were transformed with the centromeric
pWTR2(URA3) plasmid carrying a wild-type RIO2 gene under
the control of its authentic promoter. Transformants were se-
lected on plates lacking uracil; and after sporulation, tetrads
were dissected and spotted on YPD plates. Transformation of
Y22005 with an empty vector showed the expected 2:2 segre-
gation of viable and nonviable spores. PCR analysis demon-
strated that none of the viable spores contained the disrupted
rio2 gene, confirming that RIO2 is an essential gene as previ-
ously reported (31). In contrast, sporulation of Y22005 cells
carrying the pWTR2 plasmid in most cases resulted in four
viable spores. The resulting haploid transformants were tested
for G414 resistance to ascertain the presence of the disrupted
chromosomal rio2 gene as well as for their ability to grow on
plates lacking uracil to ensure retention of the plasmid. As a
final check, selected cells were analyzed by PCR to ascertain
that no recombination had taken place between the plasmid
and the genome. This resulted in strain YTV101(pWTR2) (rio2-
null), which was found to grow normally. To determine the
effect of depletion of Rio2p, we replaced the pWTR2 plasmid
with plasmid pGalR2(HIS3), which contains the wild-type
RIO2 gene under the control of the repressible GAL1-10 pro-
moter, by plasmid shuffling and determined the effect of a shift
from galactose to glucose on growth of the YTV101(pGalR2)
transformants. To our surprise, we found no significant change
in growth rate after the shift compared with the wild-type
control, for which we took cells grown from viable haploid
spores of the Y22005 strain that had been transformed with an
empty vector. Even after culturing the pGalR2-transformed
YTV101 cells for several days on glucose-based medium, nor-
mal growth was maintained (cf. Fig. 4) (data not shown). This
suggests that the small amount of protein resulting from leak-
FIG. 1. Pre-rRNA processing in S.
cerevisiae. A, structure of the rDNA re-
peat, including the processing sites used
for formation of the mature 18 S, 5.8 S,
and 25 S rRNA species. The positions of
the probes employed for Northern hybrid-
ization (Table III) are indicated. B, the
pre-rRNA processing pathway. Pol, RNA
polymerase.
FIG. 2. Sequence conservation
within and between the subfamilies of
homologous proteins defined by Rio1p
and Rio2p. Sequences for Rio1p and its
subfamily were taken from Ref. 22. Mem-
bers of the Rio2p subfamily were identified
by searching the NCBI Protein Database
with the Rio2p sequence using the Clust-
alW algorithm. Conserved regions are
shaded. The numbers within these shaded
regions indicate the percentage of sequence
identity (i) and sequence similarity (s)
within the pertinent subfamily. The num-
bers within the double-arrowed boxes indi-
cate the percentage of sequence identity
and similarity between the two subfamilies
in the particular region. The positions and
nature of the mutations introduced into
Rio2p are indicated. aa, amino acids.
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iness of the GAL1-10 promoter under repressive conditions is
sufficient to support normal growth.
Mutation of Conserved Residues in Rio2p—To circumvent
the problem posed by the requirement for only low level expres-
sion of Rio2p, we decided to introduce a number of point mu-
tations at strongly conserved positions in the protein that
might either cause temperature sensitivity or reduce its activ-
ity. We chose primarily to target conserved amino acids located
within the putative ATP-binding motif or the kinase site as
indicated in Fig. 2. The mutant genes were constructed by
site-directed mutagenesis (see “Experimental Procedures”) and
used to replace the wild-type RIO2 coding region in the pGalR2
plasmid. The resulting plasmids were then transformed into
YTV101(pWTR2) cells, and transformants were selected on
plates lacking uracil and histidine and containing glucose as
the carbon source to inhibit expression of the Rio2p mutant.
Selected cells were tested for their ability to lose the pWTR2
plasmid by streaking them on plates containing 5-fluoroorotic
acid and either galactose or glucose as the carbon source. With
a single exception, all of the transformants were able to grow on
5-fluoroorotic acid plates containing either carbon source, indi-
cating that the Rio2p mutants are functional and can support
growth even when transcription of the encoding gene is re-
pressed. The exception was the mutant in which the conserved
Asp at position 229 in the putative kinase domain had been
changed to Ala (Fig. 2). Cells expressing Rio2p containing the
D229A mutation were able to grow on galactose (but not glu-
cose)-containing plates in the presence of 5-fluoroorotic acid.
This suggests that the D229A mutation does not abolish the
activity of the protein, but does reduce this activity to such an
extent that low level expression of the repressed GAL-driven
mutant rio2 gene is insufficient for the need of the cell.
None of the Rio2p mutants displayed either temperature or
cold sensitivity or a dominant-negative growth phenotype (data
not shown). Therefore, we chose the D229A mutant to investi-
gate the function of Rio2p further.
Strain YTV101 containing either pGalR2 or pGalR2(D229A)
was grown on galactose and then shifted to glucose. As shown
in Fig. 4, the strain expressing wild-type Rio2p kept growing
with a doubling time of 2.5 h even 48 h after the shift,
confirming our conclusion that low level expression of Rio2p
from the repressed GAL-rio2 gene is sufficient to support
normal cell growth. In contrast, the growth rate of the
pGalR2(D229A) transformant, although initially identical to
its wild-type counterpart, started to decrease strongly 20 h
after the shift. Equal amounts of cells were taken from both
cultures 48 h after their transfer to glucose-containing me-
dium, and a series of consecutive 10-fold dilutions was spotted
on a yeast/peptone/galactose plate (Fig. 4, inset). No difference
in growth could be observed between the cells expressing either
the wild-type or mutant protein, indicating that depletion of
Rio2p(D229A) causes growth arrest of the cells, but, at least
initially, is not lethal. In contrast to cells depleted of Rio1p,
however (22), YTV101 cells containing the GAL-rio2(D229A)
FIG. 3. Phylogenetic tree for the
Rio1p- and Rio2p-related proteins. A
phylogenetic tree for the various Rio1p-
and Rio2p-related sequences extracted
from the data base was constructed using
the ClustalW program. Accession num-
bers for the various sequences in the
NCBI Protein Database are given.
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gene did not show any obvious morphological abnormalities
even after prolonged culturing on glucose (data not shown).
Rio2p Is Required for Processing of 20 S Pre-rRNA into
Mature 18 S rRNA—Because Rio2p has been found to be phys-
ically associated with proteins implicated in late steps in the
formation of 40 S ribosomal subunits (24), we wanted to ana-
lyze the effect of depletion of Rio2p(D229A) on ribosome bio-
genesis. To that end, total RNA was isolated from pGalR2- and
pGalR2(D229A)-transformed YTV101 cells harvested at differ-
ent times after a shift from galactose to glucose. The RNA
samples were subjected to Northern analysis using various
probes to determine the levels of the different mature and
precursor rRNA species. Whereas there was no effect on either
25 S or 18 S rRNA production in the pGalR2 transformants
(Fig. 5, lanes 1–6), depletion of Rio2p(D229A) resulted in a
progressive reduction in the level of 18 S rRNA starting
20–24 h after the shift, and the amount of 25 S rRNA re-
mained constant over a 48-h period (lanes 7–12). Furthermore,
the mutant strain showed a strong accumulation of 20 S pre-
rRNA as well as some increase in the level of 32 S pre-rRNA.
Thus, we conclude that Rio2p has a major role late in 40 S
subunit biogenesis, either in the nuclear export of the pre-40 S
particle or in the final processing cleavage at site D. The in-
crease in the level of the 32 S precursor suggests that the
absence of Rio2p may also delay the early cleavage at site A2.
This delay did not have detectable consequences for 25 S rRNA
production, however (Fig. 5).
To define the role of Rio2p in 40 S subunit biogenesis more
precisely, we analyzed the subcellular distribution of the 20 S
precursor in the Rio2p(D229A)-depleted cells using a biochem-
ical approach. Extracts from YTV101 cells expressing either
the plasmid-encoded wild-type or mutant GAL::rio2 gene were
prepared after growth on glucose for 24 h by carefully breaking
the cells, followed by separation into a nuclear and a cytoplas-
mic fraction using differential centrifugation. The level of 20 S
pre-rRNA in each of the fractions was then determined by
Northern analysis. As shown in Fig. 6, cells containing the
GAL-driven wild-type RIO2 gene contained roughly equal, low
amounts of 20 S pre-rRNA in both fractions (lanes 1 and 2). In
contrast, in cells that depend upon the GAL-driven
rio2(D229A) gene, a much higher level 20 S pre-rRNA was
found, most of which was present in the cytoplasmic fraction
(lanes 3 and 4). Both types of cells showed a very similar
distribution of 35 S and 27 S pre-rRNAs, with only a small
percentage present in the cytoplasmic fraction. Thus, the high
level of 20 S pre-rRNA found in the cytoplasmic fraction from
the mutant cells is not due to excessive leakage from damaged
nuclei. We conclude that, in cells depleted of Rio2p(D229A), the
20 S pre-rRNA does get exported from the nucleus, but fails to
be processed further.
Rio2p Is a Protein Kinase—To determine whether Rio2p is
indeed able to function as a protein kinase and whether the
D229A mutation affects this activity, we fused wild-type Rio2p
as well as Rio2p(D229A) N-terminally to GST, expressed the
fusion proteins in E. coli, and purified them from cell extracts
using glutathione-Sepharose beads (see “Experimental Proce-
dures”). When the purified material was analyzed on an SDS-
polyacrylamide gel, in both cases, a band was visible at 80
kDa, the expected molecular mass of GST-Rio2p (Fig. 7, lanes 2
and 3), and contamination with other proteins was minor.
Material purified from the control cells transformed with the
same vector containing only the GST gene produced a strong
band corresponding to GST, but no signal at the position of
GST-Rio2p (lane 1).
First, we analyzed whether Rio2p, like Rio1p (21, 22), is
capable of autophosphorylation by incubating glutathione-
FIG. 4. Growth analysis of cells expressing a plasmid-encoded
copy of the wild-type RIO2 or rio2(D229A) mutant gene under
the control of the GAL promoter. YTV101 cells transformed with
either the pGalR2 or pGalR2(D229A) plasmid were first grown on
medium containing galactose and shifted to glucose-containing medium
at time 0. Growth was followed by determining the OD660, and cells
were kept in exponential growth by diluting the culture at regular
intervals. , wild type (wt); f, D229A mutant. The inset shows the
results of growth on a galactose-containing plate of a dilution series of
wild-type and mutant cells collected 48 h after the shift to glucose.
FIG. 5. Effect of Rio2p(D229A) depletion on pre-rRNA process-
ing. YTV101 cells transformed with either the pGalR2 (lanes 1–6) or
pGalR2(D229A) (lanes 7–12) plasmid were shifted from galactose- to
glucose-containing medium, and samples were taken directly before
and at different times after the shift. Total RNA was isolated from these
samples and analyzed by Northern hybridization using the different
probes indicated in Fig. 1A and Table III.
FIG. 6. Subcellular localization of 20 S pre-rRNA in cells de-
pleted of Rio2p(D229A). YTV101 cells transformed with either the
pGalR2 (lanes 1 and 2) or pGalR2(D229A) (lanes 3 and 4) plasmid were
shifted from galactose- to glucose-containing medium. Cells were har-
vested 24 h after the shift, and nuclear (N) and cytoplasmic (C) fractions
were prepared. Total RNA was isolated from each of these fractions,
and the levels of 20 S pre-rRNA were analyzed by Northern hybridiza-
tion using probe 1 (indicated in Fig. 1A and Table III). As a control, we
also analyzed the levels of the 35 S and 27 S precursors using probes 1
and 3, respectively.
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bound GST-Rio2p and GST-Rio2p(D229A) with [-32P]ATP in a
Tris/MgCl2 buffer, followed by separation of the labeled prod-
ucts by SDS-PAGE (Fig. 8A). Both wild-type Rio2p and
Rio2p(D229A) were indeed able to phosphorylate themselves,
but the mutant protein was considerably less efficient (cf. lanes
2 and 3). No labeled products were visible in the control (lane
1), demonstrating that the kinase activity is due to the recom-
binant protein. Furthermore, in this buffer, neither the wild-
type nor mutant protein proved to be able to phosphorylate
MBP, and the addition of MBP did not affect the rate or extent
of autophosphorylation (data not shown). Therefore, we also
determined the kinase activity of wild-type Rio2p and
Rio2p(D229A) in the presence of 5 mM MnCl2, which has been
shown to improve the efficiency of both auto- and heterophos-
phorylation by Rio1p (21). As shown in Fig. 8B, the addition of
MnCl2 did not significantly affect the rate of autophosphoryl-
ation by Rio2p (Fig. 8, cf. A and B, lanes 2 and 3). However, in
the presence of MnCl2, substantial phosphorylation by wild-
type Rio2p of the heterologous substrate MBP could be ob-
served (Fig. 8B, lane 1). The D229A mutant protein was also
capable of phosphorylating MBP under these conditions, but
this activity was reduced to the same extent as its autophos-
phorylating activity (lane 2). These results demonstrate that
Rio2p is a protein kinase and that the D229A mutation signif-
icantly impairs its enzymatic activity.
As a control, we carried out similar experiments with various
other Rio2p mutants (Fig. 2). Fig. 8 (A and B, lanes 3) shows the
results for the mutant in which His227, which is absolutely
conserved in both the Rio2p and Rio1p/Rrp10p subfamilies,
was changed into Phe (Fig. 2). Clearly, both the auto- and
heterophosphorylating activities of Rio2p were only marginally
(if at all) affected by this non-conservative replacement, thus
strengthening the argument that the role of Rio2p in pre-rRNA
processing is linked to its enzymatic activity. Attempts to test
the kinase activity of the K105I mutation in the kinase domain
were unsuccessful because we were unable to express this
mutant protein in E. coli. However, the absence of a detectable
growth defect upon depletion of Rio2p(K105I) strongly indi-
cates that, like the H227F mutation, this non-conservative
replacement does not significantly affect the enzymatic
activity.
Rio2p Is Expressed at a Low Level and Is Predominantly
Nuclear—To determine the subcellular localization of Rio2p,
we used strain SC1413 (obtained from EUROSCARF), which
contains a RIO2 gene controlled by its own promoter that
encodes a TAP-tagged version of the protein. Our initial at-
tempts to localize TAP-Rio2p using indirect immunofluores-
cence did not yield any conclusive data, probably due to the
very low expression level of the protein (see below). We there-
fore again turned to biochemical fractionation. Total protein
was isolated from both the nuclear and cytoplasmic fractions
prepared from exponentially growing SC1413 cells and sepa-
rated on a 10% SDS-PAA gel. Tagged Rio2p was then visual-
ized by Western blotting using an antibody against the ProtA
moiety of the epitope tag. As a control, we performed the same
experiment with strain SC1110 expressing TAP-tagged Gar1p,
a protein known to be localized to the nucleolus (32, 33). As
shown in Fig. 9A, TAP-tagged Gar1p could be readily detected
and was indeed found predominantly in the nuclear fraction
(lane 1), although there was some contamination of the cyto-
plasmic fraction (lane 2). Analysis of the nuclear and cytoplas-
mic fractions from strain SC1413 containing the same amount
of total protein did produce a signal for TAP-Rio2p in the
nuclear fraction, which, however, was much weaker than that
obtained for TAP-Gar1p (Fig. 9B, lane 3). No Rio2p signal was
detectable in the cytoplasmic fraction (lane 4) even upon more
prolonged exposure (data not shown). From these data, we
conclude 1) that Rio2p is a predominantly nuclear protein and
2) that the cellular level of Rio2p expressed from its authentic
promoter is at least 2 orders of magnitude lower than that of
Gar1p. The latter conclusion is in agreement with our failure to
deplete Rio2p below the level required for normal growth in
cells containing a GAL-rio2 gene after a shift from galactose to
glucose.
DISCUSSION
Over the past 3 decades, biochemical and genetic screens
have identified many non-ribosomal factors essential for the
formation of ribosomes in the yeast S. cerevisiae (2, 13). The
majority possess structural (and thus presumably functional)
homologs in other organisms ranging from Caenorhabditis el-
egans to human, underscoring the strong evolutionary conser-
vation of the mechanics of eukaryotic ribosome biogenesis.
Recent experiments have made it clear that these trans-acting
factors are part of two largely independent, dynamic machin-
FIG. 7. Purification of GST-Rio2p and GST-Rio2p(D229A). GST-
Rio2p and GST-Rio2p(D229A) were expressed in E. coli and purified by
affinity chromatography using glutathione-Sepharose beads. Bound
material was analyzed by SDS-PAA gel electrophoresis, and protein
was visualized by staining with Coomassie Brilliant Blue. Lane 1,
protein purified from cells transformed with a plasmid encoding GST;
lane 2, protein from cells expressing GST-Rio2p (wild-type (WT)); lane
3, protein from cells expressing GST-Rio2p(D229A).
FIG. 8. In vitro kinase assay of recombinant wild-type Rio2p
and its mutants. Glutathione-Sepharose beads containing similar
amounts of GST-Rio2p (wild-type), GST-Rio2p(D229A), or GST(H227F)
were incubated for 30 min under different buffer conditions in the
presence of [-32P]ATP, and the labeled products were analyzed by
SDS-PAA gel electrophoresis. A, incubation in Tris-HCl (pH 7.2) con-
taining 5 mM MgCl2; B, incubation in the same buffer, but containing,
in addition, 5 mM MnCl2 as well as 4 g of MBP as heterologous
substrate; C, SDS-PAA gel electrophoretic analysis of an aliquot of the
incubation mixture to compare the amount of recombinant protein
present in the assay mixture. Lanes 1, protein from E. coli cells express-
ing only GST; lanes 2, protein from cells expressing GST-Rio2p (wild-
type); lanes 3, protein from cells expressing GST-Rio2p(D229A); lanes 4,
protein from cells expressing GST-Rio2p(H227F).
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eries that assemble on the pre-rRNA and govern its processing
and ordered assembly with the ribosomal proteins into the
small and large subunits, respectively (1, 12, 14, 15, 17). Func-
tional characterization of these factors is still in its infancy;
but, apart from the exo- and endonucleases obviously required
for the removal of the spacer regions, they are known to include
RNA helicases, modifying enzymes (methylases and pseudouri-
dylase), RNA-binding proteins, GTPases/ATPases, ribosomal
protein assembly chaperones, and factors involved in intranu-
clear transport and nuclear export (reviewed in Refs. 1, 12, 13,
and 17). Recently, protein kinases were added to this list by the
finding that Rio1p/Rrp10p, a predominantly cytoplasmic ser-
ine/threonine protein kinase (21, 22), is essential for the endo-
nucleolytic cleavage of 20 S pre-rRNA at site D that produces
mature 18 S rRNA (11). The data reported in this study identify
a second protein kinase, Rio2p, required for this final step in 18
S rRNA formation and also indicate a link between its enzy-
matic activity and 20 S pre-rRNA processing.
Rio2p shows significant sequence similarity to Rio1p/Rrp10p
and, in particular, contains the structural motifs implicated in
ATP-binding and kinase activities. However, detailed struc-
tural comparison indicated that the two proteins belong to
separate subfamilies (Figs. 2 and 3). That founded by Rio1p/
Rrp10p probably is the older one, as members of this subfamily
are found in eubacteria (20), whereas members of the Rio2p
subfamily are not. Our data base search also identified Rio-like
proteins in several (archae)bacterial species that have diverged
considerably from both Rio1p/Rrp10p and Rio2p, but do group
together, thus forming a third subfamily (Fig. 4). In yeast,
Rio1p/Rrp10p and Rio2p have non-overlapping functions be-
cause both genes are essential (this study and Ref. 22). Tran-
scriptome analysis (34) indicated that both proteins are ex-
pressed at low levels (1 molecule of mRNA/cell). However, our
data show that the requirement for Rio2p is distinctly lower
than that for Rio1p/Rrp10p. Whereas the latter protein is func-
tionally depleted by repressing transcription of a GAL-driven
gene (11, 22), GAL-rio2 cells grow at approximately wild-type
rates on both liquid and solid media containing glucose (cf. Fig.
4). Apparently, the leakiness of the GAL promoter allows produc-
tion of sufficient Rio2p to adequately cover cellular demand even
under repressive conditions. The Western blot experiment shown
in Fig. 9 further supports the conclusion that Rio2p is a low
abundant protein, expressed at a level 100-fold below that of
the small nucleolar ribonucleoprotein component Gar1p.
The lack of a detectable phenotype in GAL::rio2 cells neces-
sitated the construction of a conditional Rio2p mutant. To that
end, we mutated absolutely conserved amino acids in the ATP-
binding and kinase motifs as well as in the central region II of
a GAL::rio2 gene (Fig. 2). Six of the seven mutants constructed
remained able to support normal growth, even on glucose,
when introduced into a rio2-null strain. This included both a
conservative (Lys 3 Arg) and a non-conservative (Lys 3 Ile)
replacement at position 105 in the ATP-binding motif, replace-
ment of Met189 with either Lys or Ile in the central region, and
replacement of His227 with Tyr or Phe in the kinase domain.
Thus, none of these residues, which are also conserved in
Rio1p/Rrp10p, are essential for the function of Rio2p. However,
the seventh mutation, a non-conservative replacement of
Asp229 with Ala, did show a useful phenotype: whereas the
mutant protein remained able to support normal growth on
galactose, after a shift to glucose, a progressive decrease in the
growth rate occurred starting 20 h after the shift (Fig. 4).
Northern experiments demonstrated a concomitant reduction
in the level of 18 S rRNA, whereas production of the large
subunit rRNAs remained unaffected (Fig. 5). The reduced level
of 18 S rRNA is due to a block in cleavage of its immediate
precursor at site D rather than inhibition of nuclear export of
43 S pre-ribosomes because 20 S pre-rRNA accumulated predom-
inantly in the cytoplasm (Fig. 6). Thus, like Rio1p/Rrp10p, Rio2p
is specifically required for the final cytoplasmic processing step in
18 S rRNA formation, but at a substantially lower level. So far,
the only other example of a trans-acting factor that cannot be
functionally depleted when expressed from a GAL-driven gene is
Ngl2p, a nuclease required for the last (although nonessential)
step in 3-end formation of 5.8 S rRNA (6).
In apparent contradiction to the involvement of Rio2p in
cytoplasmic processing of 20 S pre-rRNA, biochemical fraction-
ation experiments clearly indicated that the protein is predom-
inantly located in the nucleus (Fig. 9). This finding is in agree-
ment with the presence of Rio2p in a complex containing a
number of different trans-acting factors, including Dim1p,
Rrp12p, and Tsr1p (24), which are also predominantly nuclear
(or even nucleolar) proteins involved in 40 S subunit biogenesis
(12, 35, 36). However, Dim1p is clearly part of both the nucle-
olar and cytoplasmic 40 S subunit processing/assembly ma-
chineries (35, 37), and the other components of the complex also
appear to accompany the 43 S pre-ribosome upon its export
from the nucleus (12, 18). A similar shuttling could reconcile
the requirement of Rio2p for cytoplasmic processing of 20 S
pre-rRNA with its predominant nuclear localization. In fact,
evidence for such shuttling of Rio2p was reported while this
manuscript was being revised (18, 38). However, the singularly
low level cellular demand for Rio2p suggests that it acts cata-
lytically rather than being a stoichiometric component of the 43
S pre-ribosome.
The in vitro assays using affinity-purified recombinant pro-
tein convincingly demonstrated that Rio2p is a protein kinase
capable of both auto- and heterophosphorylation (Fig. 8). How-
ever, the latter activity required the inclusion of Mn2 ions in
the incubation buffer. The significant decrease in both auto-
and heterophosphorylation caused by the D229A mutation
(Fig. 8) indicates a link between the enzymatic activity of Rio2p
and its role in 20 S pre-rRNA processing. This link is further
strengthened by the fact that the H227F mutation in the ki-
nase domain of Rio2p did not significantly affect the kinase
activity. We cannot formally exclude the possibility that the
processing phenotype of the D229A mutant is due to a lower
expression level of the mutant protein rather than a reduced
kinase activity. However, lower expression would most likely
be the result of a higher rate of turnover of the mutant protein
relative to its wild-type counterpart. We deem this possibility
to be rather remote, as mutation of the closely neighboring
His227 residue did not affect the ability of Rio2p to support
FIG. 9. Subcellular localization of Rio2p. Strains SC1110 and
SC1413 expressing TAP-tagged versions of Gar1p (lanes 1 and 2) and
Rio2p (lanes 3 and 4), respectively, were grown to mid-exponential
phase and harvested by centrifugation. Extracts were prepared and
separated into cytoplasmic (C) and nuclear (N) fractions by differential
centrifugation. The fractions were analyzed by SDS-PAA gel electro-
phoresis to compare their protein contents (B) and by Western blotting
using an antibody against the ProtA moiety of the TAP tag to determine
the level of the tagged protein (A).
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normal growth even when expressed from a GAL promoter
under repressive conditions, indicating that this mutant is
expressed at a normal level.
The physical association of Rio2p with proteins involved in
chromatin remodeling (Snf2p, Snf5p, and Swi3p) and cell cycle
progression (Bem2p and Hrr25p) (24, 25, 39) suggests that
Rio2p is a multifunctional protein with a role in both ribosome
biogenesis and cell proliferation. Cells depleted of Rio2p(D229A)
could resume growth when transferred to galactose-based me-
dium (Fig. 4), indicating that they have not reached a terminal
phenotype. However, the Rio2p-deprived cells did not show any
morphological features diagnostic of arrest at a particular
stage of the cell cycle, in contrast to Rio1p/Rrp10p-deficient
cells, the cytological analysis of which indicated arrest upon
either entrance into S phase or exit from mitosis (22).
Although the negative effect of the D229A mutation in Rio2p
on both its enzymatic activity and 20 S pre-rRNA processing
indicates a link between its enzymatic activity and its role in
cleavage of 20 S pre-rRNA at site D, the apparent multifunc-
tional character of Rio2p raises the question of whether the
pre-rRNA processing defect might be a secondary (rather than a
primary) effect. The physical association of Rio2p with the proc-
essing/assembly complex involved in the late steps of 40 S sub-
unit biogenesis (18, 24) strongly argues in favor of the latter. The
target of this enzymatic activity (either Rio2p itself or another
component of the 43 S pre-ribosome) remains to be identified.
Physical interaction of Rio1p/Rrp10p with components of the
small subunit processing/assembly machinery has not been
demonstrated directly. However, Rio1p/Rrp10p was found to
co-sediment with 20 S pre-rRNA, suggesting that it is associ-
ated with the 43 S pre-ribosome and also may act catalytically
(11). The effect of mutations that reduce its kinase activity and
cause growth arrest (22) on 20 S pre-rRNA processing remains
to be determined.
There are several precedents for proteins that function in both
cell cycle progression and pre-rRNA processing. Nop7p (also
known as Yhp1p) is required for exonucleolytic processing of 27 S
A3 pre-rRNA, whereas mutant alleles of the gene or depletion of
the protein causes growth arrest in G1 or G2 (40–42). A similar
dual function has been reported for its vertebrate homolog Pes-
cadillo (43). Erb1p is required for cleavage at site C2 within
internal transcribed spacer 2 (44) and has a mammalian homo-
log, Bop1p, mutants of which cause a strong inhibition of pre-
rRNA processing as well as a p53-dependent cell cycle arrest (45).
A third example is Ytm1p, which is also involved in 60 S subunit
biogenesis (16) and is essential for G1/S transition (46). All
three are found in 66 S pre-ribosomes (12) as well as in asso-
ciation with proteins involved in recognition of the origin of
replication, cell cycle regulation, and chromatin remodeling
(41). Thus, they are prime candidates for coordinating DNA
replication and ribosome (in particular, 60 S subunit) biogen-
esis with cell proliferation. We suggest that Rio1p/Rrp10p and
Rio2p have a similar role at the level of 40 S subunit biogenesis.
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